Last checked at 
LONDON (Alliance News) - Eco Animal Health Group PLC said Tuesday that it had received marketing authorisation for Aivlosin 42.5 milligram per gram premix, its treatment for respiratory disease in swine, in Korea.
Authorisation was granted by the Animal and Plant Quarantine Agency in Korea. Eco said that it had a long standing relationship with a distributor in South Korea who had assisted in obtaining the marketing authorisation. It expects to launch the product within a couple of months.
"This authorisation in the Republic of Korea is another encouraging and positive step in the development of Aivlosin as a fast growing, truly global brand," said Chairman Peter Lawrence in a statement.
Shares in Eco were trading up 1.0% at 208.46 pence Tuesday morning.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright © 2014 Alliance News Limited. All Rights Reserved.
